Molecular docking and binding mode analysis of selected FDA approved drugs against COVID-19 selected key protein targets: An effort towards drug repurposing to identify the combination therapy to combat COVID-19. (arXiv:2004.06447v1 [q-bio.BM]) http://arxiv.org/abs/2004.06447